Key US patent for ETSYL Technology

Summary by AI BETAClose X

BSF Enterprise PLC has received a Notice of Allowance from the United States Patent and Trademark Office for its US Patent Application No. 17/782,948, confirming patentability for proprietary methods of using ETSYL® to stimulate collagen production. This allowance, which will proceed to formal issuance after payment of an administrative fee by the December 2026 deadline, secures intellectual property protection in the significant US market for anti-ageing skincare and dermocosmetics. The patent reinforces the Company's exclusive commercialisation agreement with SCHAKAU Managementberatung GmbH for ETSYL® in cosmetics and luxury beauty, validating its cross-sector commercial applicability and enhancing long-term value for downstream sales and licensing.

Disclaimer*

UK 100